Myasthenia gravis--an autoimmune neuromuscular disease
Pirskanen-Matell, R.; Matell, G.; Kalb, B.; Bjelak, S.
Lakartidningen 97(41): 4594-4598
2000
ISSN/ISBN: 0023-7205 PMID: 11107745 Document Number: 512162
Document emailed within 1 workday
Related Documents
Bufler, J. 2010: Neuromuscular disease--myasthenia gravis MMW Fortschritte der Medizin 151(Suppl 4): 153-158Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Mapelli, G.; De Palma, P.; Franco, F.; Fini, M. 1986: Optic neuritis with an autoimmune disease (myasthenia gravis) Acta Neurologica 8(2): 141-144
Dawkins, R.L. 1975: Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia Clinical and Experimental Immunology 21(2): 185-201
De Baets, M.H. 1994: Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease Netherlands Journal of Medicine 45(6): 294-301
Pirskanen, R. 1979: Myasthenia gravis and other neuromuscular diseases Duodecim; Laaketieteellinen Aikakauskirja 95(21): 1401-1411
Pühringer, F.K.; Rex, C.; Renner, M.; Kazmaier, F. 2001: Undiagnosed myasthenia gravis unmasked by neuromuscular blockade British Journal of Anaesthesia 87(4): 650-651
De Léan, J. 1983: Effects of plasmapheresis on neuromuscular transmission in myasthenia gravis L'Union Medicale du Canada 112(1): 9-13
Nogués, M.A.; Rivero, A.; Stalberg, E. 1991: Single fiber electromyogram in myasthenia gravis and other neuromuscular diseases Medicina 51(4): 307-314
Hohlfeld, R. 1990: Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission Laboratory Investigation; a Journal of Technical Methods and Pathology 62(3): 241-243
Tan, J.H.; Ho, K.H. 2001: Familial autoimmune myasthenia gravis Singapore Medical Journal 42(4): 178-179
Jurenić, D.; Jusić, A. 1978: Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication) Neurologija 26(1-4): 37-39
Monsalve Naharro, J.A.; Gerónimo Pardo, M.; Ortiz Sánchez, V.E.; Pérez Valdivieso, J.M. 2011: Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis Revista Espanola de Anestesiologia y Reanimacion 58(10): 624-625
Castro del Río, M.; Seijo, M.; Amigo, C. 2000: Myasthenia gravis and autoimmune dysthyroidism following lymhoma Revista de Neurologia 31(11): 1099-1100
Tsujihata, M.; Hazama, R.; Ishii, N.; Ide, Y.; Takamori, M. 1979: Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases Rinsho Shinkeigaku 19(11): 751-759
Shibuya, N. 1978: A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes Rinsho Shinkeigaku 18(4): 177-184
Murakami, S. 1976: 2 cases of myasthenia gravis associated with rheumatoid arthritis - a study of autoimmune diseases Rinsho Shinkeigaku 16(2): 110-116
Müller-Hermelink, H.K.; Kirchner, T.; Hoppe, F.; Demel, S. 1988: Thymic myoid cells--stimulants and/or targets of autoimmune myasthenia gravis Monographs in Allergy 25: 68-74
Li, L.; Zhang, Y.P. 1994: Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine Zhongguo Yao Li Xue Bao 15(4): 358-362
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21